Fig. 1From: RETRACTED ARTICLE:Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathwayRelative expression of COX-2 in ESCC cell lines and prediction for function or mechanism after treatment with parecoxib. A Relative expression of COX-2 was measured in four ESCC cell lines by western blotting. B GO analysis of differentially expressed mRNA after treatment with parecoxib (300 μM), suggesting variation in cell cycle, proliferation, and cell adhesion. C KEGG analysis of pathways enriched for differentially expressed mRNA, indicating variation in cell cycle, ECM, p53, and pathways in cancerBack to article page